These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8003241)
1. Task persistence and learning ability in normal and chronic low dose MPTP-treated monkeys. Roeltgen DP; Schneider JS Behav Brain Res; 1994 Feb; 60(2):115-24. PubMed ID: 8003241 [TBL] [Abstract][Full Text] [Related]
2. Cognitive and motor deficits in the performance of an object retrieval task with a barrier-detour in monkeys (Cercopithecus aethiops sabaeus) treated with MPTP: long-term performance and effect of transparency of the barrier. Taylor JR; Roth RH; Sladek JR; Redmond DE Behav Neurosci; 1990 Aug; 104(4):564-76. PubMed ID: 2206426 [TBL] [Abstract][Full Text] [Related]
5. Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys. Slovin H; Abeles M; Vaadia E; Haalman I; Prut Y; Bergman H J Neurophysiol; 1999 Feb; 81(2):858-74. PubMed ID: 10036286 [TBL] [Abstract][Full Text] [Related]
6. Effects of dihydrexidine, a full dopamine D-1 receptor agonist, on delayed response performance in chronic low dose MPTP-treated monkeys. Schneider JS; Sun ZQ; Roeltgen DP Brain Res; 1994 Nov; 663(1):140-4. PubMed ID: 7850462 [TBL] [Abstract][Full Text] [Related]
7. Effects of dopamine agonists on delayed response performance in chronic low-dose MPTP-treated monkeys. Schneider JS; Sun ZQ; Roeltgen DP Pharmacol Biochem Behav; 1994 May; 48(1):235-40. PubMed ID: 7913226 [TBL] [Abstract][Full Text] [Related]
8. Effects of nicotinic therapies on attention and executive functions in chronic low-dose MPTP-treated monkeys. Decamp E; Schneider JS Eur J Neurosci; 2006 Oct; 24(7):2098-104. PubMed ID: 17067307 [TBL] [Abstract][Full Text] [Related]
9. The subtype-selective nicotinic acetylcholine receptor agonist SIB-1553A improves both attention and memory components of a spatial working memory task in chronic low dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys. Schneider JS; Tinker JP; Menzaghi F; Lloyd GK J Pharmacol Exp Ther; 2003 Jul; 306(1):401-6. PubMed ID: 12721323 [TBL] [Abstract][Full Text] [Related]
10. Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey. Schneider JS; Pope-Coleman A Neurodegeneration; 1995 Sep; 4(3):245-55. PubMed ID: 8581557 [TBL] [Abstract][Full Text] [Related]
12. Attention and executive function deficits in chronic low-dose MPTP-treated non-human primates. Decamp E; Schneider JS Eur J Neurosci; 2004 Sep; 20(5):1371-8. PubMed ID: 15341609 [TBL] [Abstract][Full Text] [Related]
13. Chronic low-dose MPTP in nonhuman primates: a possible model for attention deficit disorder. Roeltgen DP; Schneider JS J Child Neurol; 1991; 6 Suppl():S82-9. PubMed ID: 2002219 [TBL] [Abstract][Full Text] [Related]
14. Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys. Schneider JS; Kovelowski CJ Brain Res; 1990 Jun; 519(1-2):122-8. PubMed ID: 2397401 [TBL] [Abstract][Full Text] [Related]
15. Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys. Taylor JR; Elsworth JD; Roth RH; Sladek JR; Redmond DE Brain; 1990 Jun; 113 ( Pt 3)():617-37. PubMed ID: 2364263 [TBL] [Abstract][Full Text] [Related]
16. A novel dopamine D3R agonist SK609 with norepinephrine transporter inhibition promotes improvement in cognitive task performance in rodent and non-human primate models of Parkinson's disease. Schneider JS; Marshall CA; Keibel L; Snyder NW; Hill MP; Brotchie JM; Johnston TH; Waterhouse BD; Kortagere S Exp Neurol; 2021 Jan; 335():113514. PubMed ID: 33141071 [TBL] [Abstract][Full Text] [Related]
17. Effects of the prolyl endopeptidase inhibitor S 17092 on cognitive deficits in chronic low dose MPTP-treated monkeys. Schneider JS; Giardiniere M; Morain P Neuropsychopharmacology; 2002 Feb; 26(2):176-82. PubMed ID: 11790513 [TBL] [Abstract][Full Text] [Related]
18. The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. Sawaguchi T; Goldman-Rakic PS J Neurophysiol; 1994 Feb; 71(2):515-28. PubMed ID: 7909839 [TBL] [Abstract][Full Text] [Related]
19. Effects of the nicotinic acetylcholine receptor agonist SIB-1508Y on object retrieval performance in MPTP-treated monkeys: comparison with levodopa treatment. Schneider JS; Van Velson M; Menzaghi F; Lloyd GK Ann Neurol; 1998 Mar; 43(3):311-7. PubMed ID: 9506547 [TBL] [Abstract][Full Text] [Related]
20. Deficits in reaction times and movement times as correlates of hypokinesia in monkeys with MPTP-induced striatal dopamine depletion. Schultz W; Studer A; Romo R; Sundström E; Jonsson G; Scarnati E J Neurophysiol; 1989 Mar; 61(3):651-68. PubMed ID: 2785168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]